MedPath

SOMNOL 30MG

SOMNOL 30MG

Discontinued
DIN Number

00483818

Drug Class

Human

Market Date

Dec 31, 1981

Company
HC

axxess pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00483818
AIG Number0108704001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05CD01 FLURAZEPAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

FLURAZEPAM HYDROCHLORIDEActive
Strength: 30 MG
Monograph: FLURAZEPAM HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.